502
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Montelukast in the management of allergic rhinitis

&
Pages 327-332 | Published online: 28 Dec 2022

References

  • [AAAAI] American Academy of Allergy, Asthma, and ImmunologyThe allergy report [online]2000 Accessed 22 November 2005. URL: http://www.aaaai.org/ar/volume1.pdf
  • BernsteinDILevyALHampelFCTreatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitisClin Exp Allergy200434952715196285
  • BjornsdottirUSJakobinudottirSRunarsdottirVThe effect of reducing levels of car allergen (Fel d 1) on clinical symptoms in patients with cat allergyAnn Allergy Asthma Immunol2003911899412952114
  • BousquetJLundVJvan CauwenbergePImplementation of guidelines for seasonal allergic rhinits:a randomized controlled trialAllergy2003587334112859551
  • BousquetJvan CauwenbergePKhaltaevNAllergic rhinitis and its impact on asthmaJ Allergy Clin Immunol2001108S14733411707753
  • CorradoOJGouldCAKassabJYNasal response of rhinitic and non-rhinitic subjects to histamine and methacholine: a comparative studyThorax19864186383547756
  • CorrenJAdinoffADIrvinCGNasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthmaJ Allergy Clin Immunol19929025061500629
  • CorrenJAllergic rhinitis and asthma: how important is the link?J Allergy Clin Immunol199799S78169042071
  • CustovicAvan WijkRGThe effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma : ARIA update (in collaboration with GA2LEN)Allergy20056011121516076293
  • DykewiczMSFinemanSSkonerDPDiagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and ImmunologyAnn Allergy Asthma Immunol1998814785189860027
  • Gerth-van-WijkRDiegesPHNasal hyper-responsiveness to histamine, methacholine and phentolamine in patients with perennial nonallergic rhinitis and in patients with infectious rhinitisClin Otolaryngol19911613372070527
  • GotzschePCHammarquistCBurrMHouse dust mite control measures in the management of asthma : meta-analysisBMJ1998317110510 discussion, 11109784442
  • GrafPHallenHJutoJEFour-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivityActa Otolaryngol19951157157762389
  • GrafPHallenHEffect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal spraysLaryngoscope199610660598628089
  • JordanaGDolovichJBriscoeMPIntranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitisJ Allergy Clin Immunol199697588958621843
  • KilburnSLassersonTJMcKeanMPet allergen control measures for allergic asthma in children and adultsCochrane Database Syst Rev20011CD00298912535446
  • KurowskiMKunaPGorskiPMontelukast plus ceterizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammationAllergy200459280814982509
  • LedfordDKLockeyRFAllergic rhinitis: Understanding the process (a major contributor to health problems-and on the rise)J Respir Dis19981957684
  • MalmLGerth-van-WijkRBachertCGuildelines for nasal provocations with aspects on nasal patency, airflow, and airflow resitanceRhinology199937133510567994
  • MarkhamAFauldsDMontelukastDrugs19985625169711449
  • MartinBAndrewsCPvan BavelJHComparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptomsAnn Allergy Asthma Immunol200596851716802774
  • McMenaminPCosts of hay fever in the United States in 1990Ann Allergy1994733598030800
  • MeltzerEOMalmstromKLuSConcomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trialJ Allergy Clin Immunol20001059172210808172
  • NathanRAMeltzerEOSelnerJCPrevalence of allergic rhinitis in the United StatesJ Allergy Clin Immunol199799S808S14
  • NayakASPhilipGLuSEfficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double blind, placebo controlled trial performed in the fallAnn Allergy Asthma Immunol20028859260012086367
  • PatelPPhilipGYangWRandomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitisAnn Allergy Asthma Immunol200595551716400895
  • PerryTTCorrenJPhilipGProtective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposureAnn Allergy Asthma Immunol200493431815562881
  • PhilipGMalmstromKHampelFCMontelukast for treating seasonal allergic rhinitis: a randomized, double blind, placebo-control-led trial performed in the springClin Exp Allergy2002321020812100048
  • PhilipGNayakABergerWThe effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitisCurr Med Res Opin20041015495815462688
  • PhipatanakulWNowak-WegrzynAEgglestonPAThe efficacy of montelukast in the treatment of cat allergen-induced asthma in childrenJ Allergy Clin Immunol2002109794911994702
  • PulleritsTPraksLRistiojaVComparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitisJ Allergy Clin Immunol20021099495512063523
  • RatnerPHHowlandWCArastuRFluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukastAnn Allergy Asthma Immunol20031095364212775135
  • RayNFBaraniukJNThamerMDirect expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnessesJ Allergy Clin Immunology1999103401710069872
  • Singulair PISingulair prescribing information2005Whitehouse Station, NJMerck & Co. Inc. June 1998–2005
  • TogiasAUnique mechanistic features of allergic rhinitisJ Allergy Clin Immunol200090599604
  • TopuzBOgmenGGMontelukast as an adjuvant to mainstay therapies in patients with seasonal allergic rhinitisClin Exp Allergy200333823612801319
  • van AdelsbergJPhilipGLaForceCFRandomized controlled trial evaluating clinical benefit of montelukast for treating spring seasonal allergic rhinitisAnn Allergy Asthma Immunol2003902142212602669
  • van AdelsbergJPhilipGPedinoffAJMontelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment periodAllergy20035812687614616102
  • van CauwenbergePBachertCPassalacquaGConsensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical ImmunologyAllergy2000551163410726726
  • WelshPWStrickerWEChuCPEfficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergyMayo Clin Proc198762125343100877
  • WhiteMVKalinerMAMediators of allergic rhinitisJ Allergy Clin Immunol1992906997041401652
  • WilsonAMOrrLCSimsEJEffects of monotherapy with intranasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitsClin Exp Allergy20013161811167952
  • WilsonAMSimsEJOrrLCEffects of topical corticosteroids and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitisAnn Allergy Asthma Immunol200187344911686428